Bayhill Therapeutics, Inc. — Form D

Bayhill Therapeutics, Inc. of San Mateo, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-07-17. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2009-07-17
• Form: D
• Accession: 0001181431-09-035658
• Industry: Pharmaceuticals
• Exemptions: 06
• Total offering: $10.0M
• Amount sold: $10.0M
• Investors: 1
• Date of first sale: 2009-06-10
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-65425

Issuer

• Name: Bayhill Therapeutics, Inc.
• CIK: 0001290157
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 1810 Gateway Drive, Suite 150, San Mateo, CA, 94404
• Phone: (650) 320-2800

Officers, directors & promoters (13)

More

• CIK 1290157 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search